Signify Health Investor Conference Presentation Deck

-> Attractive financial model, growth, and profitability $502 signifyhealth. 2019 Revenue ($ in millions) CAGR: 23% (2) $611 2020 $755-770E 2021 Guidance 1) See Appendix for "Reconciliation from GAAP net loss to Adjusted EBITDA" for a reconciliation of Adjusted EBITDA to net loss and the calculation of Adjusted EBITDA Margin 2) Reflects mid-point of 2021 guidance range Adjusted EBITDA(1) ($ in millions) $93 2019 CAGR: 33% (2) $125 2020 $160-170E 2021 Guidance Current visibility to 20%+ 2022 revenue and corresponding Adj. EBITDA growth 13

View entire presentation